During the past decade, National Center of Urology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Center of Urology" are "Benign Prostatic Hyperplasia" (1 trials), "Cancer" (1 trials), "Intravesical Bacteriophage Treatment for Urinary Tract Infections" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "National Center of Urology" in a lesser frequency.

Most popular intervention types in "National Center of Urology" are "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antibiotics" (1 trials), "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Center of Urology" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "National Center of Urology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Center of Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Center of Urology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".